Niraparib tosylate monohydrate is a salt-hydrate form of the active pharmaceutical ingredient niraparib. It is a PARP inhibitor used as a pharmaceutical raw material in the manufacturing of anticancer medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1613220-15-7
Niraparib
pharmaceutical raw material
Zerbaxa
pharmaceutical raw material
2',3'-di-O-acetyl-5'-deoxy-5-fluorocytidine
pharmaceutical raw material
[2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine Hydrochloride
pharmaceutical raw material
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
pharmaceutical raw material
4-methylbenzenesulfonic acid;2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;hydrate
ACNPUCQQZDAPJH-FMOMHUKBSA-N
CC1=CC=C(C=C1)S(=O)(=O)O.C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.O